Search

You searched for "macula"

877 results found
Ophthalmologica journal cover image

Rebound phenomenon after IVT triamcinolone acetonide for macular oedema

7 April 2021 | | EYE - Vitreo-Retinal
In this retrospective study, the authors report the rebound phenomenon after intravitreal triamcinolone acetonide (IVTA) injection for macular oedema secondary to diabetic retinopathy (DR) and central (CRVO) or branch retinal vein occlusion (BRVO). The incidence of a rebound phenomenon was...
Ophthalmologica journal cover image.

Traumatic macular holes: reconstructive changes in foveal microstructures and visual predictor analysis, following surgical repair

5 April 2022 | | EYE - Vitreo-Retinal
The purpose of this paper was to investigate the reconstructive changes in foveal microstructures postoperatively and analyse the visual predictors in eyes with surgically closed traumatic macular holes (TMHs). This retrospective study analysed the data collected from 71 eyes of...
Ophthalmologica journal cover image.

Autofluorescence patterns in subretinal haemorrhages associated with neovascular age-related macular degeneration

2 August 2024 | | EYE - Vitreo-Retinal
The aim of this retrospective study was to describe the surgical results and fundus autofluorescence (FAF) patterns occurring in sub-macular haemorrhage (SMH) of duration <60 days in age-related macular degeneration (AMD). Notes from 39 eyes of 39 patients with SMH,...
Ophthalmologica journal front cover image.

IVTA for diabetic macular edema and macular edema secondary to retinal vein occlusion: a meta-analysis

1 August 2024 | | EYE - Vitreo-Retinal
This meta-analysis aimed to compare the safety and efficacy of different doses of intravitreal triamcinolone acetonide (IVTA) for diabetic macular oedema (DME) and macular oedema (ME) secondary to retinal vein occlusion (RVO). A systematic literature search for randomised controlled trials...

Vabysmo receives NICE approval

27 September 2024 | Awards, Conferences & Anniversaries, Company Profiles, Research & Development
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...

CHEC Loughborough CPD Open Evening

24 April 2025
This CPD session on 'Decoding Macular OCT: Mastering Membranes and Holes - Empowering Optometrists in Referral Decision-Making' will be hosted by Mahmoud Rabie, Consultant Ophthalmologist and Clinical Director of Ophthalmology at CHEC. Throughout the evening, you will be able to...

Cortical blindness

1 August 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Cortical blindness is a rare but recognised entity. Cerebrovascular accident is a well-known risk factor. We report a case of an 84-year-old lady with bilateral cortical blindness with multiple cardiovascular risk factors. Case report An 84-year-old lady was admitted under...

An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection

1 December 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....

Diabetic Retinopathy Network laser training programme

5 February 2020 | | EYE - Vitreo-Retinal, EYE - General
The VISION 2020 Diabetic Retinopathy Network (DR-NET) was established in 2014 to tackle the increasing burden of diabetes and diabetic retinopathy (DR) in developing countries [1]. By forming a network of long-term LINK capacity-building partnerships, learning and best practice can...

Genetic profiling for personalised healthcare solutions in AMD – an update

1 August 2015 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...

Pituitary tumours: why are they so often missed?

1 October 2017 | | EYE - Neuro-ophthalmology
Part 3: Clinical features, assessment and management (see also Part 2, and Part 1) As previously mentioned in this treatise [1] pituitary tumours are common, occur in all age groups and can present with anything from minimal visual symptoms to...

What’s next in retinal imaging? Faster, deeper and full-on

1 April 2015 | | EYE - Vitreo-Retinal, EYE - Imaging
Fast-evolving technological leaps are opening the way toward clinically useful ocular coherence angiography, generating 3-dimensional microvasculature maps without intravenous dye injection, as well as whole-eye imaging, handheld patient-operated optical coherence tomography (OCT) devices and, for challenging vitreoretinal procedures, integrated intraoperative...